Form D · Biotechnology
NantBio, Inc.
El Segundo, CA · CIK 0001608318
Offering snapshot reported Nov 13, 2023 · SEC filing
- Reported sold
- $75.1M Offering amount: $75.1M
- Investors reported
- 6 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Nov 8, 2023 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Nov 13, 2023 | Initial | $75,073,925 | No comparison | 6 | SEC filing |
| Jun 2, 2015 | Amendment | $10,000,000 | -$90,000,000vs May 12, 2015 | 1 | SEC filing |
| May 12, 2015 | Initial | $100,000,000 | No comparison | 1 | SEC filing |
| Feb 6, 2015 | Initial | $45,000,000 | No comparison | 1 | SEC filing |
| Oct 30, 2014 | Initial | $25,000,000 | No comparison | 1 | SEC filing |
| May 16, 2014 | Initial | $25,000,000 | No comparison | 1 | SEC filing |
Offering details
- Securities
- Equity, Debt
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- Yes
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-496950
Source: Form D, filed Nov 13, 2023. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| James Banaag | Executive |
| Charles Kenworthy | Director, Executive |
| Douglas Reed Maughan | Director |
| Patrick Shoon Shiong | Director |
| Patrick Soon Shiong | Director, Executive |
Issuer details
Industry: Biotechnology (See others in industry)
Address:
450 Duley Road
El Segundo, CA, 90245
El Segundo, CA, 90245